{"database": "lobbying", "table": "lobbying_activities", "rows": [[967347, "80821f9d-78da-48d0-a861-0f5678a2afed", "2T", "CAPITOL DECISIONS, INC.", 55165, "INOVEON CORP.", 2010, "second_quarter", "VET", "Digital Diabetic Retinopathy technology", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 1, "2010-07-20T04:41:02.897000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["967347"], "units": {}, "query_ms": 35.07888701278716, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}